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X, show highest mRNA levels in the brain.
Conclusions: A novel member of the nuclear RNA export factor family is
absent in a male patient with a syndromic form of mental retardation. Although
we did not find direct evidence for the involvement of NXF5 in MR, the gene
could be involved in development, possibly through a process in mRNA
metabolism in neurons.
Background the precise mechanism of interplay has yet to be discov-
ered. Nuclear export of mRNA to the cytoplasm is aX-linked mental retardation (XLMR) is clinically variable
and genetically heterogeneous. Mental retardation (MR) signal-mediated, energy-dependent, and highly selective
process of which many steps are still unclear [4]. Theis considered to be a developmental brain disorder. The
impact of genetic factors on this development is estimated human protein TAP/NXF1 has been proposed to function
as a nuclear export receptor for mRNA [5]. TAP/NXF1at 35% in severe MR (IQ  50) and 15% in mild MR
(50  IQ  70). Recent advances in molecular genetics binds RNA and other RNA binding proteins and shuttles
between the nucleus and the cytoplasm [5–7]. The TAP/and positional cloning led to the identification of genes
NXF1 protein contains three main functional domains:that might be instrumental for cognitive development
the N-terminal part (residues 1–372), which binds RNA;[1–3]. The identification of such genes should help to
the middle part (residues 371–551), which binds p15/improve our knowledge of the molecular and cellular
NXT; and the C-terminal ubiquitin-associated (UBA)-mechanisms underlying the physiological and pathophysi-
like domain (residues 508–619), which binds proteins ofological development of cognitive functions.
the nuclear pore complex (NPC) [5, 8]. Evidence for the
involvement of TAP/NXF1 in nuclear export of mRNAThe generation of eukaryotic mRNAs involves a number
of processes (transcription, splicing, capping, polyadenyla- has been obtained from studies in yeast and in Caenorhab-
ditis elegans in which the TAP orthologs, Mex67p andtion, nuclear export, transport, translation, and decay) that
are tightly regulated by a broad range of interacting mole- CeNXF1, respectively, have been demonstrated to be
essential for this process [9, 10]. Also, indirect evidencecules. The identification of all these molecules as well as
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for TAP/NXF1-mediated export of cellular mRNAs has estimated at 50 kb. In addition, a particularly interesting
case of a boy (SB) with amicrodeletion onXp21 extendingbeen published [11–13]. Recently, it was suggested that
the interaction of TAP/NXF1 with p15/NXT is required from CYBB to RPGR was described [16, 17]. SB was re-
ported to have chronic granulomatous disease, retinitisfor efficient mRNA export [14].
pigmentosa, and McLeod phenotype. This patient was
In this study, we report on the identification of a novel not mentally handicapped (de Saint Basile, personal com-
gene, NXF5, that might be associated with a syndromic munication). The extent of the Xp deletion in SB was
form of XLMR through investigation of an inv(X) confirmed in our lab by PCR-based STS mapping (data
(p21.1;q22) in a male patient. The novel gene at Xq is not shown). From these results, we conclude that the
split by the breakpoint, leading to its functional nullisomy. potential MR gene is not at the Xp breakpoint.
The gene shows high similarity to the mRNA nuclear
export factor TAP/NXF1, and it is part of a cluster of The Xq breakpoint is present in an NXF gene cluster
and leads to functional nullisomy of NXF5homologous genes, since three additional genes were
We analyzed the Xq22 region using the genomic se-identified within a region of 1 Mb on Xq22. Functional
quences of clones cV434E11, cV411C11, and dJ232L22analysis of NXF5 demonstrated general affinity for RNA
(Figure 1a). Several predicted exon sequences showedas well as for the TAP/NXF1-associated protein p15/
similarity to the mRNA nuclear export factor TAP/NXF1.NXT. In contrast to TAP/NXF1, which localizes to the
Primers derived from the potential exons were used fornucleus, NXF5 is also localized in the cytoplasm of cul-
RT-PCR and RACE-PCR experiments as described intured cells andmore importantly in the form of aggregates
the Materials and methods. Using human fetal brainin the cell body as well as in some of the neurites of
polyA() RNA as well as total RNA derived from EBV-mature hippocampal neurons. Screening of mouse BAC
transformed cell lines, we cloned the complete NXF5clone filters and database searches identified two novel
gene. Detection of exon-intron boundaries by the compar-mouse nxf homologs, nxf-a and nxf-b. Although the general
ison of genomic and cDNA sequences revealed the exis-mRNA expression levels are low, the highest expression
tence of 19 exons. NXF5 potentially codes for at least fiveof both genes was found in the brain of adult mice. For
different protein isoforms (NXF5a–e; GenBank accessionnxf-a, even higher levels were found at E7.5 dpc whole
numbers AJ277654–AJ277658, respectively) derived fromembryos. Taken together, our results indicate that the
alternative splicing of the transcript affecting the presenceinterruption of the human NXF5 gene affects the normal
of exons 4 and 5, the choice of acceptor sites in exons 9development, including the cognitive network, possibly
and 16, and the choice of donor site in exon 15 (Figure 1b).via its function in mRNA metabolism. However, no dis-
In all isoforms, the putative translation initiation codon,ease-associated mutations have been identified so far.
which is in agreement with the Kozak consensus se-
quence, is present in exon 3. The largest isoform (NXF5a)Results
reveals a single ORF of 1191 nt that encodes a proteinCloning the breakpoints of inv(X)(p21.1;q22)
of 397 amino acids. The Xq breakpoint is positioned inDetails on the cloning of the breakpoints will be described
intron 1 of NXF5 and therefore does not interrupt theelsewhere (S. Frints et al., unpublished data). Briefly, the
presumed coding sequence. In order to define whetherbreakpoints were defined by FISH analysis using a cluster
the breakpoint interferes with the NXF5 mRNA expres-of YACs at Xp11.4–22. First, the YAC clone 790d6 and
sion, RT-PCR was performed, starting with total RNAlater the PAC clone dJ1051h1 were shown to span the
from EBV-transformed cell lines of A059 and of controls.Xp breakpoint. Restriction map analysis, Southern blot
After heminested PCR analysis, specific amplification ofhybridization, and vectorette-based cloning approaches
the coding region of NXF5 was obtained for the controlsperformed according to standard procedures revealed the
but not for the A059-derived sample (Figure 1c). Amplifi-sequences at both breakpoints in patient A059. The Xq
cation of GAPD and -actin were taken as controls. Posi-breakpoint could be located in a sequenced cosmid
tion effects of the Xq breakpoint on genes in the direct(cV434E11) from Xq22.
neighborhood of NXF5 were examined by RT-PCR. At
the Xqter side of NXF5, expression of NXF2 and NXF3The potential disease gene is not at the Xp breakpoint
Since two chromosome X regions are affected by the was investigated by heminested PCR. Centromeric to the
NXF gene cluster, transcripts of two genes of the recentlyinversion, we had to define which locus (Xp or Xq) con-
tains a potential MR-associated gene. A map of the Xp mapped ALEX gene cluster (ALEX1 and ALEX2) [18] as
well as the GLA gene were quantified. No significantbreakpoint was generated, and analysis of an 40-kb ran-
dom sequence with different gene prediction programs expression changes were observed between the patient
and controls for any of the genes investigated. Each quan-only detected the SRPX gene. A literature search [15, 16]
identified a gene contig at the Xp breakpoint “CYBB- titation was done in triplicate, of which Figure 1c shows
a representative result. Since the region selected for am-TCTEIL-breakpoint-SRPX-RPGR-OTC”. The shortest
distance between the breakpoint and a gene (SRPX) was plification of NXF5 is present in all isoforms, divergence
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Figure 1 of isoform usage can be excluded. These results show
that NXF5 mRNA expression is completely shut off by
the inversion, and, hence, no protein is produced.
Three additional genomic clones on Xq22 (cV618H1,
cU221F2, and dJ1100E15) were identified by BLAST to
contain sequences highly similar to NXF5. In addition,
ESTs derived from or partially derived from these geno-
mic clones reveal homology to NXF5 and TAP/NXF1.
Using RT-PCR and RACE approaches, we obtained the
full-length cDNA sequence ofNXF2 (GenBank accession
number AJ277659), derived from cV618H1, and a partial
cDNA sequence of NXF3 (GenBank accession number
AJ277660), derived from cU221F2. A potential NXF gene
present in dJ1100E15 (NXF4) most probably is a pseu-
dogene, since it contains stop codons in all reading frames
shortly after the presumed start codon. The NXF gene
cluster is located within a region of approximately 1 Mb
between the GLA and PLP genes. The genomic orga-
nization is “Xcen-GLA-ALEX-NXF5-NXF2-NXF4-NXF3-
PLP-Xqter” (Figure 1a). The complete cDNA sequences
of NXF2 and NXF3 have recently been described [13].
Mutation screening did not reveal
a disease-associated mutation
Detailed information on this screen will be described
elsewhere (S. Frints et al., unpublished data). Briefly, we
combined SSCP with sequencing of PCR products that
showed aberrant SSCP patterns to detect potential point
mutations in the exons and their flanking intron se-
quences for the NXF2 and NXF5 genes. A total of 115
probands from XLMR and supposed XLMR families,
either syndromic or nonspecific, were selected for SSCP
analysis. For 17 of these families, the disease locus was
mapped to Xq22. A different SSCP pattern amongst the
probands was observed in four positions of NXF5 and in
two positions of NXF2. Four of these changes showed a
high frequency (10%) in the screened population. The
STSs are indicated as DXS numbers. Note that the figure is not drawn
to scale. (b) A scheme of the genomic organization of NXF5 and
its different isoforms. The position of the clones covering the gene is
indicated at the top. Exons are shown as numbered boxes. Exons with
alternative splice sites are marked with an asterisk. The exon usage
of the five isoforms (a–e) was determined by RT-PCR, with the
predicted start codon located in the third exon of each isoform (gray
boxes). The coding regions are shown as black bars, and the exons
containing the stop codon are indicated in black. (c) The expression
of NXF5 is abolished in the patient. Heminested RT-PCR was
performed for the detection of NXF5 mRNA expression on cDNAs
derived from EBV-transformed cell lines of the patient (A059) andThe breakpoint at Xq interrupts the novel gene NXF5 within the NXF
two control individuals (Co1 and Co2). Negative PCR controls aregene cluster. (a) A schematic representation of the genomic region
indicated by a hyphen. Expression of genes in the directcontaining the breakpoint at Xq. The breakpoint is located in clone
neighborhood of NXF5 was checked by RT-PCR. These genes arecV434E11 and maps at Xq22. The positions of neighboring clones
NXF2 and NXF3 at the telomeric side and ALEX1, ALEX2, and GLAin this region are shown by horizontal bars. Sequence analysis revealed
at the centromeric side of the Xq breakpoint. The housekeeping genesthe presence of a gene cluster consisting of four highly homologous
GAPD and -actin were also included. PCR products were analyzedsequences oriented as Xcen-NXF5-NXF2-NXF4-NXF3-Xqter and
on a 1.5% agarose gel.pinpoints the breakpoint in the first intron of the NXF5 gene. The
NXF4 pseudogene is represented by the light box. The positions of
1384 Current Biology Vol 11 No 18
Figure 2
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two changes with a frequency  5% were checked in 54%. However, all attempts to amplify this presumed
gene on a genomic as well as on a cDNA level failed.a control population and found to be single-nucleotide
polymorphisms. Therefore, we cannot yet define this single EST as an
nxf homolog. In order to screen for additional nxf homologs
The predicted structure of the novel NXF proteins reveal as well as to isolate mouse nxf genomic sequences, we
homology with TAP/NXF1 used different fragments of the nxf-a and nxf-b genes,
BLAST analysis showed that all members of the NXF covering the entire coding regions, to screen a mouse
gene cluster encode proteins that reveal significant simi- genomic BAC library. The positive BAC clones 417D19
larity to human, mouse, and rat TAP/NXF1. Alignment of and 420L6 contain genomic sequences of the nxf-a gene,
the human and mouse NXF proteins is illustrated in Fig- while the nxf-b genomic sequences were identified in
ure 2. TAP/NXF1 consists of three functional domains: BAC 277M12 and 452M12, as determined by PCR and
anN-terminal domain (residues 1–372), which binds RNA partial sequence analysis. In this screen, we were unable
and several RNA binding proteins, a p15/NXT-hetero- to identify BAC clones containing other nxf genes, includ-
dimerization domain (middle part), and a C-terminal nu- ing the nxf-c gene. The almost complete genomic se-
clear pore complex (NPC) binding region [4, 13]. The quence of nxf-b is now available from contig AC024363.
N-terminal domain of TAP/NXF1 includes a noncanoni- FISH experiments mapped both nxf genes to mouse chro-
cal RNP-type RNA binding domain (RBD), four leucine- mosome X. Moreover, both signals are present at the
rich repeats (LRRs), and a region of more divergent se- same location, indicating that a similar nxf gene cluster is
quences N-terminal to the RBD [19]. The NXF2 and present on the mouse X chromosome. Alignment of the
NXF3 proteins show 74% and 72% similarity, respec- predicted proteinswith their human counterparts is shown
tively, to TAP/NXF1, with conservation of the structural in Figure 2. Note that nxf-b contains an additional 70-
domains [13]. If TAP/NXF1 is taken as a reference, the amino acid domain that consists of a repeat of 13–15 amino
NXF5 protein starts at position 107 and comprises the acids (RNLQNGK[L]GLIVPT). This repeat domain
conserved RBD and the LRRs but lacks the most diver- does not show any homology with other protein regions.
gent sequences N-terminal to the RBD. The p15/NXT It is yet not possible to define the exact orthology of the
binding domain is also highly conserved but lacks a stretch human andmouseNXF genes, except for TAP/NXF1. The
of 35 amino acids (394–429 in TAP/NXF1). The C-termi- identity of the nxf-a protein with humanNXF2,NXF3, and
nal domain of NXF5 is much shorter, with a conserved NXF5 is 73%, 69%, and 71%, respectively. For nxf-b, the
N-terminal part but a completely different C terminus. identity is 71%, 67%, and 72%, respectively. The identity
between human and mouse TAP/NXF1 is 82%.
Identification of two novel nxf homologs in the mouse
To define the mouse orthologs of the novel NXF genes, NXF genes are low-abundance genes with predominant
we screened mouse BAC filters and searched the mouse expression in the brain of mice
EST database at NCBI with the cDNA sequences of A human multiple tissue Northern blot hybridization did
NXF5 and NXF2. Database searches revealed, in addi- not reveal any signals for NXF2 or NXF5, indicating that
tion to murine TAP/nxf1, three potential nxf homologs, both represent low-abundance transcripts. Our previous
which we called nxf-a (GenBank accession numbers results obtained from RT-PCR and RACE experiments
AA474219 and AW543149), nxf-b (GenBank accession on fetal brain-derived and EBV-transformed cell line-
number AW555775), and nxf-c (GenBank accession num- derived cDNAs point in the same direction, since two
ber AW543152). RACE experiments were performed, and rounds of PCR were always required in order to detect
sequences of the full-length nxf-a and partial nxf-b genes the amplicons. Moreover, not a singleNXF5-derived EST
were submitted to GenBank (accession numbersAJ305318 was found in human databases. Temporal and spatial ex-
and AJ305319, respectively). Meanwhile, the cDNA se- pression patterns of mouse nxf-a and nxf-b were investi-
quence of nxf-b (also called nxf2) was obtained by two gated by real-time quantitation. RNA samples derived
independent groups (GenBank accession numbers frommouse embryos at different stages and from different
NM_031259 and AY017476). The similarity of full-length tissues of adult mice were analyzed. Each nxf primer/
nxf-a and nxf-b with the mouse TAP/NXF1 protein is probe combination was first validated to check the ampli-
fication efficiency with that of the endogenous control,63% and 70%, respectively. For the available C-terminal
sequence of the presumed nxf-c protein, the similarity is -actin. This allows for a comparison between the two nxf
Multiple sequence alignment of the NXF family of proteins of human TAP/NXF1 protein. The ribonucleoprotein (RNP) consensus motif
and mouse. CLUSTALW alignment of human NXF1/TAP, NXF2, NXF3, regions, RNP1 and RNP2, are boxed. HuNXF5a lacks the most
and NXF5a and mouse mTAP/nxf1, nxf-a, and nxf-b/nxf2. The domain N- and C-terminal sequences. The unique repeat motif of nxf-b/nxf2
structures indicated below the alignment (RBD, LRR, p15 binding is present within the LRR.
domain, and NPC binding domain) are based on the human
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Figure 3
Relative mRNA expression levels of the mouse
nxf-a and nxf-b genes. The expression was
quantified by the Taqman procedure on the
ABI-PRISM7700 from total RNA samples
extracted from mouse embryos at different
stages (E7.5–E19.5) and from tissues of
adult mice. Expression levels of nxf-a (light
bars) and nxf-b (dark bars) were first normalized
toward the housekeeping gene -actin
(comparative CT method) and then mutually
compared based on the similar nxf-a and nxf-b
mRNA levels in the liver sample.
Consequently, the fold differences of both
genes can be relatively compared. The fold-
increase values obtained for nxf-a in the E7.5
and brain samples are given above the bar.
genes based on -actin mRNA levels. Equal normalized to the RNA probe; however, the NXF5a-RNA complexes
migrate slower than the NXF2-RNA complexes, sug-amounts for nxf-a and nxf-b mRNAs were demonstrated
in the liver sample, so this was used as the calibrator to gesting that the former complexes may contain multiple
NXF5 molecules. This binding is nonspecific, since itwhich each sample was compared. As is the case forNXF2
and NXF5, both mouse nxf genes are also low-abundance was competed for by tRNA. Binding of in vitro-translated
NXF5a to p15-1 and p15-2a fused to GST was analyzedgenes. Starting from as much as 50 ng reverse-transcribed
RNA, 35 cycles were not sufficient for most of the samples in a GST pull-down assay. As demonstrated in Figure 4b,
both p15/NXT proteins bind to NXF5a as well as to theto generate a fluorescence signal that reached the thresh-
old value. As can be seen in Figure 3, expression of nxf-a positive control, TAP/NXF1. This means that the TAP/
NXF1 region 394–429, which is absent in NXF5, is notat the early stage of the embryo was very high (E7.5 dpc),
then dropped significantly at E9.5 dpc and stayed low essential for p15/NXT binding. The N-terminal domain
of TAP/NXF1 (1–372) did not bind to the fusion proteins,until E19.5 dpc. In the adult mouse, the highest expres-
sion was found in the brain (Ct  28), with substantial while GST alone did not associate with either of the NXF
proteins. GST pull-down experiments did not reveal anyexpression in the cerebral cortex. In all other tissues
tested, including the cerebellum, the mRNA levels are binding of NXF5 to the nucleoporin fusion product, GST-
CAN (data not shown). The construct used for localizationmore than 20-times below those obtained in the brain.
Subsequently, RNA in situ hybridization was performed of NXF5a (EGFP-NXF5a) in the monkey CV-1 and hu-
man NT2 cell lines demonstrated that NXF5a is mainlyon E19.5 dpc embryos and adult brain sections with differ-
ent nxf-a probes, but we could not detect any signals in present in the cytoplasm of the cells, although nuclear
staining, with the exclusion of the nucleoli, was also no-either of the samples (data not shown). Levels of nxf-b
mRNA were also highest in the brain of adult mice, but ticeable (Figure 4c). The reverse fusion constructNXF5a-
EGFP demonstrated a similar staining pattern (data notwhen compared to nxf-a, the expression here was about
5-times lower (Figure 3). The cerebral cortex seems to shown). The control EGFP-TAP fusion protein was ex-
contribute most to these levels, although expression in clusively localized in the nucleus. In contrast to TAP/
the cerebellum was also noticed. Compared to the liver NXF1, NXF5 did not localize to the nuclear rim (data not
calibrator sample, the nxf-b mRNA levels were also ele- shown). Intracellular distribution of overexpressed GFP-
vated in the spleen and testes, while those in all other NXF5 and GFP-TAP/NXF1 in fully mature hippocampal
samples tested stayed very low. neurons in culture (11 days) demonstrated intense GFP-
NXF5 fluorescence in the entire cell body and in the
form of small aggregates in some of the neurites, mostNXF5 binds RNA and p15/NXT and localizes as granules
likely the cell’s dendrites (Figure 4d). GFP-TAP/NXF1 isin the cytoplasm of hippocampal cells
largely, if not exclusively, concentrated in the cell nucleus,The RNA binding affinity of NXF5 was tested with the
with a clear enrichment in the nuclear membrane.predicted RNA binding domain (RBD; amino acids 1–92)
of NXF5a fused to GST. The purified GST-RBD fusion
Discussionproduct was incubated with an RNA probe, and the re-
We have identified and characterized anNXF gene clustersulting complexes were analyzed in a gel mobility retarda-
through investigation of the Xq breakpoint of antion assay (Figure 4a). The RBD of NXF2 was taken as
a positive control, while the same region of NXF3 was inv(X)(p21.1;q22) in a male patient (A059) with a syn-
dromic form of mental retardation. The gene cluster onused as a negative control [13]. The RBD of NXF5 bound
Research Paper Loss of the NXF5 gene in an XLMR patient Jun et al. 1387
Figure 4
Binding and localization studies of NXF5a. (a)
A gel mobility shift assay was performed with
[32P]UTP random RNA probe (10,000 dpm/
reaction), produced by in vitro transcription
of the polylinker of pBluescript-SK with the
Ampliscribe T7 transcription kit and 1 g
purified RNA binding domains of GST-NXF2,
GST-NXF3, and GST-NXF5a. Unlabeled
competitor tRNA was added as indicated
above the lanes. Mixtures were incubated for
30 min at 30C and run on a 5% native PAA
gel in 0.5  TBE at 210 V for 2 hr. Dried
gels were exposed overnight to X-Omat film
at –70C. The free RNA probe is indicated
at the right. (b) GST pull-down assay with p15
proteins. Binding assays were performed
with in vitro-translated [35S]methionine TAP,
TAP(1-372), or NXF5a and immobilized
GST, GST-p15-1, or GST-p15-2a on
glutathione agarose beads. One tenth of the
input and one quarter of the bound fraction
for each protein was analyzed on 12% PAA
SDS-PAGE. Dried gels were exposed to
BioMax film at –70C. (c) Intracellular
distribution in monkey CV-1 and human NT2
cells of the EGFP-TAP and EGFP-NXF5a
constructs (0.5 g plasmid/2.104 cells/well).
EGFP alone was used as a negative control.
After transfection of the DNA constructs with
the FuGENE6 transfection reagent, cells
were incubated for 20 hr and fixed with 4%
formaldehyde for 15 min. Signals were
visualized with a MRC 1024 confocal
microscope. (d) Intracellular distribution in
mature hippocampal neurons of E18 rats.
Primary hippocampal neurons were seeded
at 105 cells/well on poly-L-lysine-coated
coverslips and kept in 5% CO2 at 36.5C.
After 7 hr, the coverslips were transferred to
a 6-cm dish containing astrocytes in minimal
essential medium (MEM) and N2 constructs coding for EGFP-NXF5 and EGFP- After 24 hr, neurons were fixed with 4%
supplements. Ten-day-old hippocampal TAP/NXF1 (0.8 g for every threecoverslips) paraformaldehyde and mounted for
neurons were transfected with cDNA using EffecteneTM transfection reagent. microscopic observation.
Xq22 consists of four genes organized as Xcen-NXF5- these results, it is likely that the protein is involved in
posttranscriptional regulation of mRNA, and, therefore,NXF2-NXF4-NXF3-Xpter. NXF5 is disrupted in its 5	
UTR by the inversion, leading to its functional nullisomy. the question arises whether the loss of NXF5 results in
altered mRNA metabolism in the MR patient.Mutation analysis detected four polymorphisms, but did
not reveal any disease-related nucleotide changes. NXF5
shows high sequence similarity with the nuclear export The breakpoint in the gene is situated in the 5	 UTR
between exons 1 and 2. Consequently, no expression isfactor TAP/NXF1 and was shown to bind to RNA as well
as to the p15/NXT proteins. However, in contradiction detectable in the EBV-transformed cell line derived from
A059, whereas cell lines from controls yield an amplifica-to TAP/NXF1, it is predominantly localized in the cyto-
plasm of cells and more particularly in the cell body and tion product after heminested RT-PCR. Whether the
NXF5 promoter induces the transcription of a gene atneurites of hippocampal neurons. The NXF5 gene, of
which at least five isoforms exist, seems to be expressed Xp21.1 remains to be further investigated, although ex-
tensive database analyses did not reveal the presence ofat low abundance. In the adult mouse, the expression of
the presumed orthologs nxf-a and nxf-b is highest in the a gene in the neighborhood of the Xp breakpoint. Dele-
tion of a region extending the Xp breakpoint, as wasbrain when compared to other tissues, pointing to a brain-
specific role. Interestingly, compared to those found in the described in one boy [17], did not result in MR, indicating
that no MR gene is present in this deleted region and,brain, 20-fold higher levels of nxf-amRNA are detected at
E7.5 dpc, the time point at which neurulation starts. From hence, position effects of the Xp breakpoint can also be
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excluded. However, we cannot exclude a gain-of-function (position 397). The existence of additional isoforms can-
not be excluded.resulting from the overexpression of a gene onXp. Screen-
ing for a potential position effect of the Xq breakpoint
It is not clear yet whether the NXF gene cluster in manon the most neighboring genes (within a 0.4-Mb interval
is evolutionary conserved in mice. Beside mouse TAP/at each side) did not reveal an altered expression pattern
nxf1, we identified three potential nxf genes in databasefor any of these genes in the patient compared to controls
searches (nxf-a, -b, and -c). All attempts to amplify differ-providing strong evidence for the involvement of NXF5.
ent regions of the presumed nxf-c gene at the cDNA or
genomic DNA level failed. This suggests that the pub-The structural organization of the NXF2 protein is highly
similar to that of TAP/NXF1. It consists of an N-terminal lished sequence of this EST could be artifactual. Based
on the complete nxf-a and nxf-b cDNA sequences, wedomain containing the RBD and the leucine-rich repeats,
a middle NTF2-like domain that binds p15/NXT, and were not able to determine which mouse homolog is the
ortholog of human NXF5. Both genes contain the com-an NPC binding domain at the C-terminal end of the
protein [5, 13, 19]. Recently, NXF2 has been shown to plete NPC binding domain, which is absent in NXF5.
Interestingly, the BACs containing nxf-a and -b genes bothbind to RNA, p15/NXT, and nucleoporins [13]. The same
study demonstrated NXF3 binding to p15/NXT, but no map at the same position of the mouse X chromosome,
indicating the presence of a similar nxf gene cluster inaffinity for RNA or nucleoporins was observed. Prelimi-
nary functional analysis of NXF5 was performed using the mouse genome. Mapping of the nxf-b (nxf2) gene to
mouse chromosome X was also recently described [24]. Inthe isoform with the longest ORF (NXF5a). NXF5a con-
tains a truncated N-terminal domain and NPC binding the same study, the nxf-b (nxf2) mRNAwas predominantly
found in mouse testes and was identified as a spermatogo-domain but an almost complete p15/NXT-heterodimeri-
zation domain. Our studies demonstrate that NXF5a is nia-specific gene.
able to bind to RNA as well as to the p15/NXT proteins,
The involvement of RNA binding proteins in cognitivep15-1 and p15-2a, suggesting that it may contribute to
development has already been implicated by studying themRNAnuclear export. p15/NXThas recently been shown
to act as a cofactor in the TAP/NXF1-dependent export fragile-X-associated protein, FMRP, responsible for the
of RNA [14, 20]. However, the NXF5a protein does not most common form of inherited mental retardation [25].
bind nucleoporins in vitro nor localizes at the nuclear rim Indeed, FMRP has been demonstrated to bind RNA in
in vivo, consistent with the absence of a C-terminal NPC vitro [26, 27] and to contain sequence motifs that are
binding domain. In this context, it is possible that the commonly found in RNA binding proteins. FMRP is also
shorter NXF forms (NXF3 and NXF5), which do not endowed with a nuclear localization signal (NLS) and a
bind to nucleoporins, act as regulatory proteins for the nuclear export signal (NES), suggesting that it shuttles
export factors TAP/NXF1 and NXF2. The existence of between the nucleus and the cytoplasm. In addition,
several isoforms might create an evenmore complex regu- FMRP is associated with ribosomes in an RNA-depen-
latory system. Alternatively, NXF proteins lacking the dent manner [28, 29]. In situ hybridization experiments
NPC binding domain may have a different function from in mouse brain demonstrated that FMRP is expressed at
nuclear export. Indeed, in contrast to TAP/NXF1, which elevated levels in neurons of the cortex and hippocampus.
is mainly localized within the nucleus, both NXF5 and Besides the involvement in RNA binding, the existence
NXF3 are also detected in the cytoplasm, suggesting a of different NXF5 isoforms resembles the situation of
cytoplasmic function. In this respect, the granular somato- FMR1 as well as its homologs FXR1 and FXR2. Localiza-
dendritic localization of NXF5 in hippocampal neurons, tion studies of some of these isoforms report a specific
reminiscent of the labeling seen for both the endogenous spatial expression pattern [30–32]. This suggests a specific
and overexpressed staufen in the same cells [21, 22], sug- function for each of the different isoforms, but this re-
gests a role in polarized cytoplasmic transport and localiza- mains to be further investigated. Differential interaction
tion of mRNAs in neurons. It is speculated that such with other proteins, like NUFIP, might represent another
proteins play a role in synaptic plasticity [23]. The pub- way to create specificity [33]. A similar mechanism has
lished suggested amino acid sequence of NXF5 [13] was been proposed for NXF proteins through their interaction
derived from the genomic sequence and contains two stop with different partners [13]. Recently, FMRP has been
codons (depicted as x in Figure 3 of this reference). Our proposed as a negative regulator of translation through
RACEexperiments revealed the correct cDNA and amino inhibition of the assembly of 80S ribosomes on the target
acid sequences of five NXF5 isoforms. The highly diver- mRNA [34].
gent amino acid sequence at the C-terminal part of NXF5,
compared to TAP/NXF1 and NXF2, is due to an alterna- NXF5 as well as NXF2 mRNA expression levels are low,
since successful amplification always needed two roundstive splice acceptor site used in exon 15 of NXF5 (exon
22 in NXF2). This causes a frame shift (position 349 of PCR and their mRNAs could not be detected on a
multiple tissue Northern blot. In the mouse system, weof NXF5) and, subsequently, a premature stop codon
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studied the temporal and spatial expression of nxf-a and patient by the gene interruption might result in derange-
ment of the export or transport of specificmRNAs, leadingnxf-bmRNAs by real-time quantitation. Interestingly, the
to this phenotype.highest expression of both genes was obtained in the brain
of adult mice. The levels of nxf-a in the cerebral cortex
Our study suggests that interruption of this novel gene,can account for the major part of the relatively high levels
NXF5, is associated with a disease phenotype includingin the brain. The elevated levels in the brain of adult
mental retardation and short stature. One of the majormice can already be noticed at the embryonic stage E19.5
challenges will be to determine whether processes in thedpc. The relative extremely high expression levels at E7.5
metabolism of a particular subset of mRNAs is affecteddpc might be indicative of an important role for this gene
in brain cells by knocking out the NXF5 gene product.product in embryonic development. At this time point,
substantial cell proliferation occurs with subsequent orga-
Materials and methodsnization of the major systems of the embryo followed
Patient descriptionby neurulation. Expression of other genes involved in
Patient A059 is a 59-year-old male. He was clinically diagnosed withcognitive development, like IL1RAPL and TM4SF2, are
moderate to severe MR. He had a short stature, pectus excavatum,
predominantly found in the hippocampus and cortex of general muscle wasting, and facial dysmorphism including hyperte-
the brain [35, 36]. We did not yet include hippocampus lorism, large protruding ears, long nose, big mouth, and small chin.
His karyotype revealed a pericentric inversion of the X chromosome:in this study. In situ hybridization of nxf-a on E19.5 dpc
46,Y,inv(X)(p21.1;q22). This patient will be described elsewhere in moreand brain sections did not reveal any signals, most proba-
detail (S. Frints et al., unpublished data).
bly due to current restrictions in sensitivity. Compared
to nxf-a, the nxf-b mRNA levels are about 5-fold lower in Genomic clone resources and structure analysis
the brain. Again, cerebral cortex levels were highest, but YACs at Xp11.4–22 are from the Genome Research database of the
Whitehead Institute/MIT Center (WCX.6; http://carbon.wi.mit.edu:expression was also noticed in the cerebellum, spleen,
8000/cgi-bin/contig/phys_map). The PAC clone dJ1051h1 that mappedand testes. It is not yet clear why Page et al. could not
at the Xp breakpoint was obtained from Roswell Park Cancer Institute
identify nxf-b (nxf2) in the brain [24]. The use of different (http://www.roswellpark.org/). An integrated STS/YAC physical, genetic
primer sets that amplify different isoforms might be a and transcript map of Xq21.3–q23/24 is available [38, 39]. A particular
region of Xq22, from DXS366 to DXS87, where the Xq breakpointpotential explanation. The available ESTs from these
mapped, was sequenced in the Sanger Center (CHR_Xctg18; http://genes were almost all derived from E7.5 dpc libraries
www.sanger.ac.uk/HGP/ChrX/). We determined exon-intron boundaries
(except one obtained from an ovary-derived library). through sequence comparison between cloned cDNA and genomic DNA
available from the Sanger Center (http://www.sanger.ac.uk/HGP/ChrX/).
An extensive SSCP mutation analysis study, followed by
RACE and SSCP analysissequence analysis of aberrant bands, was performed for
Total RNA from EBV-transformed human PBLs or from mouse tissue wasthe NXF5 and NXF2 genomic sequences (S. Frints et
extracted with the Trizol reagent (Life Technologies). RACE experiments
al., unpublished). Two silent mutations and one intronic were performed on total RNA or directly on human fetal brain Marathon-
polymorphism in the NXF5 gene and one silent mutation Ready cDNA (Clontech) with oligo(dT)14–18 or random hexamers ac-
cording to standard procedures [40]. For mouse transcripts, total RNAand one intronic polymorphism in NXF2 were identified
from the brain was used as the source. RACE products were clonedin our MR patient-derived samples. A number of MR loci
into pGEM-T-easy vectors (Promega) for subsequent sequence analysis.
have been linked to Xq22, although these usually fail to Screening for mutations in exons and their flanking intron sequences of
exclude more distal regions. No deletion syndromes are the NXF5 and NXF2 genes was performed with standard SSCP methods
[40], except that the analysis was done on multiplexed amplicons ofreported in this region, and only a few studies report
varying lengths. The analysis was performed on probands from XLMRa cytogenetically recognizable Xq duplication, including
families, which map at Xq22, and on single-case male MR patients (S.
Xq22, which is also associated with mental retardation Frints et al., unpublished data).
and short stature [37]. So, if mutations exist in this gene,
they will be very rare, as is the case for many disease- NXF expression in patient A059
The expression levels of the NXF2, NXF3, NXF5, ALEX1, ALEX2, GLA,associated genes.
 -actin, and GAPD genes in patient A059 and controls were determined
from EBV-transformed PBLs by RT-PCR according to standard proce-
Conclusions dures [40]. Heminested PCR was performed for NXF2, NXF3, and NXF5.
We identified a novel member of the nuclear RNA export The other genes were amplified in single PCR runs of 32 cycles for
-actin and GAPD, 38 cycles for ALEX1, and 35 cycles for ALEX2factor family through investigation of a centromeric inver-
and GLA. Primer sequences can be obtained from the Supplementarysion of the X chromosome in a male patient with a syn-
material available with this article online.
dromic form of mental retardation. Binding of NXF5 to
RNA and p15/NXT supports a role in nuclear RNA ex- Identification and expression of mouse orthologs
To identify mouse orthologs of the human NXF genes, the mouse ESTport, although localization studies suggest a function in
database at NCBI (http://www3.ncbi.nlm.nih.gov/) was searched withRNA transport. Expression profiling of two potential
NXF cDNA sequences. The mouse BAC ES (II) filter (IncyteGenomics)mouse orthologs point to a brain-specific function. In addi-
containing 36,864 individual clones with a genomic coverage of 3
tion, a role in early development is suggested for one of was first hybridized with an NXF5-derived probe for which the sequence
is 98% identical to NXF2. The mouse TAP/nxf1 cDNA probe coveringthese genes. Therefore, the nullisomy in the male MR
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the same region was used as a control. Later, the same filters were manufacturer instructions. Cells were incubated overnight with the trans-
fection mixture and transferred afterwards to glia-conditioned N2 me-hybridized with different regions of the mouse nxf-a and nxf-b ORFs
dium. After 24 hr, neurons were fixed with 4% paraformaldehyde andaccording to standard procedures [40]. Determination of similarity per-
mounted for microscopic observation.centages was done by WU-blast analysis (http://www.proweb.org/
proweb/Tools/WU-blast.html). Gene-specific PCR products were quan-
Supplementary materialtified in real-time on an ABI PRISM 7700 Sequence Detection System
Supplementary material including descriptions of primers and probes(Applied BioSystems). Total RNA was extracted from mouse embryos
that were used in this study for the amplication of genes is available(E) at different stages as well as from various tissues of adult Swiss
at http://images.cellpress.com/supmat/supmatin.htm. Table 1 gives themice (total brain, cerebral cortex, cerebellum, heart, intestine, liver, lung,
primers used in RT-PCR and RACE experiments, and Table 2 givesspleen, testes, and uterus). For the embryo-derived samples, whole em-
those for real-time quantitation.bryos were taken for E7.5 and E9.5, total head was used for E11.5 and
E13.5, and fetal brain was dissected from E15.5, E17.5, and E19.5
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